Streetbeat News

OGI

OrganiGram Holdings Inc.

https://www.organigram.ca

Industry

Drug Manufacturers - Specialty & Generic

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Open

1.50

Mkt cap

156M

Volume

493K

High

1.50

P/E Ratio

-0.80

52-wk high

2.91

Low

1.44

Div yield

N/A

52-wk low

1.19

Canadian cannabis companies outperformed their American counterparts last week, with significant gains in stock prices for companies like Aurora Cannabis, Tilray Brands, Cronos Group, Organigram, and Canopy Growth. In contrast, American multi-state operators showed more modest gains. The U.S. cannabis market presents a significant risk-reward opportunity, particularly for MSOs, despite regulatory challenges.

Portfolio Pulse from Rolando García

July 16, 2024 | 10:25 pm

The article reports on the stock movements of various marijuana-related companies on July 4, 2024. Notable gainers include Heritage Cannabis Holding, Global Compliance, and Greenlane Holdings, while significant losers include GreenGro Technologies and MJ Holdings.

Portfolio Pulse from Benzinga Insights

July 05, 2024 | 3:00 pm

On July 3, 2024, several cannabis stocks experienced significant price movements. Notable gainers included Kaya Holdings (OTC:KAYS) with a 154.44% increase and Aurora Cannabis (NASDAQ:ACB) with an 8.42% increase. Among the losers, GreenGro Technologies (OTC:GRNH) saw a 90.00% decline. The article highlights the performance of various cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

July 05, 2024 | 2:59 pm

Decibel Cannabis Co. (OTCQB:DBCCF) faces market challenges with a 16% revenue drop in Q1 2024, despite leading the infused pre-roll segment in Canada. Increased competition and changing consumer trends have impacted sales and margins. The company is implementing cost-saving initiatives and new product launches to address these issues. Decibel's stock has dropped 53% over the last three months, contrasting with a 27% decline in the MSOS ETF and a 4% increase in the S&P 500.

Portfolio Pulse from Nicolás Jose Rodriguez

July 03, 2024 | 1:59 pm

Aurora Cannabis (NASDAQ:ACB) has received a neutral rating from analyst Pablo Zuanic, who highlights the company's potential in international markets but also notes the challenges it faces. Aurora's financial projections show significant improvements, but the company must prove its growth strategies amid a competitive landscape. Other companies like Cronos Group (NASDAQ:CRON), Canopy Growth (NASDAQ:CGC), SNDL (NASDAQ:SNDL), Village Farms International (NASDAQ:VFF), and Organigram (NASDAQ:OGI) are also mentioned in the context of U.S. market strategies.

Portfolio Pulse from Nicolás Jose Rodriguez

June 28, 2024 | 7:13 pm

Marijuana stocks experienced a bullish Wednesday with several companies seeing significant gains. Affinor Growers, Blueberries Medical, and Charlotte's Web Holdings were among the top gainers. However, some companies like Cara Therapeutics and MJ Holdings saw declines.

Portfolio Pulse from Benzinga Insights

June 26, 2024 | 8:30 pm

The financial performance of U.S. cannabis companies is outpacing their Canadian counterparts, with U.S. firms like Curaleaf, Green Thumb Industries, Trulieve, and Ascend Wellness showing more favorable EV/EBITDA and P/CFO ratios. U.S. companies are also projected to have a higher Adjusted EBITDA CAGR, driven by expanding legalization and a larger market. Canadian firms like Aurora Cannabis, Tilray, Canopy Growth, and OrganiGram face higher valuations and slower growth.

Portfolio Pulse from Nicolás Jose Rodriguez

June 25, 2024 | 11:01 pm

Organigram Holdings Inc. (NASDAQ:OGI) announced a $15 million investment in Berlin-based Sanity Group GmbH to expand its presence in the European cannabis market. The investment includes an unsecured convertible note and equity purchase, along with a new supply agreement. Sanity Group holds a significant share of the German medical cannabis market and is involved in a Swiss recreational cannabis pilot program.

Portfolio Pulse from Jelena Martinovic

June 25, 2024 | 3:39 pm

On June 19, 2024, several marijuana stocks experienced significant price movements. Notable gainers included Elixinol Wellness (OTC:ELLXF), Target Group (OTC:CBDY), and Psychemedics (NASDAQ:PMD). Conversely, Global Compliance (OTC:FUAPF) and Heritage Cannabis Holding (OTC:HERTF) were among the biggest losers.

Portfolio Pulse from Benzinga Insights

June 19, 2024 | 8:30 pm

Tim Seymour, portfolio manager of the Amplify Seymour Cannabis ETF (NYSE:CNBS), discusses the growth potential in the cannabis sector, emphasizing the importance of strategic partnerships, operational efficiencies, and the burgeoning U.S. hemp cannabinoid market. He highlights companies like Curaleaf, Green Thumb Industries, and Trulieve for their strong market positions and governance. Seymour also notes British Tobacco's investment in Organigram as a strategic move to expand international market reach.

Portfolio Pulse from Nicolás Jose Rodriguez

June 17, 2024 | 1:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.